Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of “indigestible” prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1–secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. SCFAs raise intracellular calcium in identified colonic L cells. A: Mixed colonic cultures were loaded with fura2-AM. Pseudocolor images of fura2 340:380 nm fluorescence ratio (reflecting [Ca2+]i) shown prior to (basal) and during the application of propionate (1 mmol/L), and after washing with saline. B: Identification of an L cell in the field of view shown in A identified by the fluorescence of Venus (475 nm excitation). C: A representative response of an L and a non–L cell recorded as in A. D: Mean calcium changes in L cells (filled bars) and non–L cells (open bars) after the addition of acetate (1 mmol/L), propionate (1 mmol/L), or CFMB (30 μmol/L) as indicated. Ratios (340:380) in the presence of the test agent were normalized to the mean of the background ratios of each cell measured before addition and after washout of the test compound. Data represent the means ± SEM of the number of cells indicated above each bar. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with baseline and ##P < 0.01 and ###P < 0.001 compared with non–L cells by Student t test. (A high-quality digital representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/c242c8ac43cc4c669f03082b05300a60/short-chain-fatty-acids-stimulate-glucagon-like-peptide-1-secretion-via-the-g-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFA-induced activation of receptors on enteroendocrine cells can promote gut-brain signaling by inducing hormones such as glucagon-like peptide 1 (GLP1) and peptide YY (PYY), as well as neurotransmitters like GABA and serotonin (276).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [276]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in rodents show that the administration of prebiotics that influences a shift in the gut microbiome toward increased production of butyrate has beneficial effects associated with higher levels of GLP-1 (193–195), as well as hypothalamic expression of pro-opiomelanocortin (196), thereby influencing the hunger-satiety cycle.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [193]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can stimulate the secretion of GLP-1 and PYY through the FFAR2 and, to a lesser extent, the FFAR3 receptor (Lin et al., 2012;Psichas et al., 2015;Tolhurst et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Tolhurst et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, SCFA can stimulate the release of GLP-1 in vitro and in vivo dependently of the FFA receptor 2 (Figure 1) [237].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [237]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 8×
“Secreted and cellular GLP-1 was extracted as previously described (24), and active GLP-1 was quantified by ELISA (Millipore).”
MethodInfluentialSelf-citationXiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 731
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43
Hong, Y.-H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.-C., Feng, D. D., Chen, C., Lee, H.-G., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0545 · Cited by 612
Cited by
Items 601–700 of 1,015
Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors
Bloes, D. A., Kretschmer, D., & Peschel, A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3390 · Cited by 73
Hanatani, S., Motoshima, H., Takaki, Y., Kawasaki, S., Igata, M., Matsumura, T., Kondo, T., Senokuchi, T., Ishii, N., Kawashima, J., et al. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-23 · Cited by 73
The role of the vagus nerve in appetite control: Implications for the pathogenesis of obesity
Cork, S. C. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12643 · Cited by 77
Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications
Yamashiro, K., Kurita, N., Urabe, T., & Hattori, N. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000516398 · Cited by 78
Peña-Durán, E., García-Galindo, J. J., López-Murillo, L. D., Huerta-Huerta, A., Balleza-Alejandri, L. R., Beltrán-Ramírez, A., Anaya-Ambriz, E. J., & Suárez-Rico, D. O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041773 · Cited by 82
Contributions of Colonic Short-Chain Fatty Acid Receptors in Energy Homeostasis
Kuwahara, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00144 · Cited by 80
Gut microbiota: a potential manipulator for host adipose tissue and energy metabolism
Bohan, R., Tianyu, X., Tiantian, Z., Ruonan, F., Hongtao, H., Qiong, W., & Chao, S. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.020 · Cited by 72
Chemogenetics defines receptor-mediated functions of short chain free fatty acids
Bolognini, D., Barki, N., Butcher, A. J., Hudson, B. D., Sergeev, E., Molloy, C., Hodge, D., Bradley, S. J., Le Gouill, C., Bouvier, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0270-1 · Cited by 74
Microbiota modulation by eating patterns and diet composition: impact on food intake
Klingbeil, E., & de La Serre, C. B. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00037.2018 · Cited by 71
Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes
Sharma, B. R., Jaiswal, S., & Veeranna, R. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113148 · Cited by 79
Digesting the complex metabolic effects of diet on the host and microbiome
Carmody, R. N., Varady, K. A., & Turnbaugh, P. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.032 · Cited by 80
Short-chain Fatty Acids: A Link Between Prebiotics And Microbiota In Chronic Kidney Disease
Esgalhado, M., Kemp, J. A., Damasceno, N. R., Fouque, D., & Mafra, D. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0059 · Cited by 68
Gut microbiota and aging-A focus on centenarians
Cӑtoi, A. F., Corina, A., Katsiki, N., Vodnar, D. C., Andreicuț, A. D., Stoian, A. P., Rizzo, M., & Pérez-Martínez, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165765 · Cited by 70
Maruta, H., & Yamashita, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239428 · Cited by 74
Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 78
Cheng, W., Ho, J. Y. S., & Chang, R. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101620 · Cited by 74
Overduin, J., Schoterman, M. H. C., Calame, W., Schonewille, A. J., & Ten Bruggencate, S. J. M. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512003066 · Cited by 70
Billing, L. J., Smith, C. A., Larraufie, P., Goldspink, D. A., Galvin, S., Kay, R. G., Howe, J. D., Walker, R., Pruna, M., Glass, L., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.011 · Cited by 70
Self-citationHuman microflora, probiotics and wound healing
Tsiouris, C. G., & Tsiouri, M. G. (2017) · Wound Medicine · doi:10.1016/j.wndm.2017.09.006 · Cited by 76
H. pylori Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans
Cornejo-Pareja, I. M., Martín‐Núñez, G. M., ROCA-RODRIGUEZ, M. M., Cardona, F., Coín‐Aragüez, L., Sánchez‐Alcoholado, L., Gutiérrez‐Repiso, C., Muñoz‐Garach, A., Fernández‐García, J. C., Moreno‐Indias, I., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040451 · Cited by 74
Impact of protein on the composition and metabolism of the human gut microbiota and health
Duncan, S. H., Iyer, A. B., & Russell, W. R. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120008022 · Cited by 78
Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease
Secor, J. D., Fligor, S. C., Tsikis, S. T., Yu, L. J., & Puder, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.656441 · Cited by 81
Gowd, V., Xie, L., Zheng, X., & Chen, W. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1576025 · Cited by 73
Gut microbiota: a non-target victim of pesticide-induced toxicity
Sharma, T., Natesh, N. S., Pothuraju, R., Batra, S. K., & Rachagani, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2187578 · Cited by 73
Hsu, C., Khachatryan, L., Younis, N. K., Mustafa, M. A., Ahmad, N., Athab, Z. H., Валерьевна, П. А., Викторовна, К. Е., Mirzaei, R., & Karampoor, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1456793 · Cited by 82
Complex Pharmacology of Novel Allosteric Free Fatty Acid 3 Receptor Ligands
Hudson, B. D., Christiansen, E., Murdoch, H., Jenkins, L., Hansen, A. H., Madsen, O., Ulven, T., & Milligan, G. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093294 · Cited by 71
Bifari, F., Ruocco, C., Decimo, I., Fumagalli, G. F., Valerio, A., & Nisoli, E. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0582-2 · Cited by 73
Targeted Approaches for In Situ Gut Microbiome Manipulation
Lee, H. L., Shen, H., Hwang, I. Y., Ling, H., Yew, W. S., Lee, Y. S., & Chang, M. W. (2018) · Genes · doi:10.3390/genes9070351 · Cited by 71
Huazano-García, A., Shin, H., & López, M. (2017) · Nutrients · doi:10.3390/nu9080821 · Cited by 67
Zhang, X., Grosfeld, A., Williams, E., Vasiliauskas, D., Barretto, S. A., Smith, L., Mariadassou, M., Philippe, C., Devime, F., Melchior, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801526rr · Cited by 73
Environmental enteric dysfunction: gut and microbiota adaptation in pregnancy and infancy
Cowardin, C. A., Syed, S., Iqbal, N. T., Jamil, Z., Sadiq, K., Iqbal, J., Ali, A., & Moore, S. R. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00714-7 · Cited by 78
Liu, T., Sun, Z., Yang, Z., & Qiao, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114586 · Cited by 73
The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis
Guan, X. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00096.2014 · Cited by 68
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment
Xu, Y., Zhou, H., & Zhu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00106 · Cited by 66
Gut bacteria interaction with vagal afferents
Cawthon, C. R., & Serre, C. B. D. L. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.012 · Cited by 74
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Signalling in the gut endocrine axis
Gribble, F. M., & Reimann, F. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.02.039 · Cited by 66
Self-citationFree Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases
Bartoszek, A., Moo, E. V., Binienda, A., Fabisiak, A., Krajewska, J. B., Mosińska, P., Niewinna, K., Tarasiuk, A., Martemyanov, K. A., Sałaga, M., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104604 · Cited by 66
Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota
Jiao, W., Zhang, Z., Xu, Y., Gong, L., Zhang, W., Tang, H. T., Zeng, S., Zhang, Q., Sun, Z., Liu, L., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15880 · Cited by 68
Microbiota and body weight control: Weight watchers within?
Boscaini, S., Leigh, S., Lavelle, A., García‐Cabrerizo, R., Lipuma, T., Clarke, G. A., Schellekens, H., & Cryan, J. F. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101427 · Cited by 74
Liu, W., Luo, Z., Zhou, J., & Sun, B. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.853771 · Cited by 77
Liu, H., Xing, Y., Wang, Y., Ren, X., Zhang, D., Dai, J., Xiu, Z., Yu, S., & Dong, Y. (2023) · Foods · doi:10.3390/foods12122310 · Cited by 67
Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., & Fu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519925 · Cited by 82
Perspectives on the therapeutic potential of short-chain fatty acid receptors
Kim, S., Kim, J.-H., Park, B. O., & Kwak, Y. S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.272 · Cited by 65
Microbiome impact on metabolism and function of sex, thyroid, growth and parathyroid hormones.
Kunc, M., Gabrych, A., & Witkowski, J. M. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1093 · Cited by 67
Hansen, N. W., & Sams, A. (2018) · Nutrients · doi:10.3390/nu10111590 · Cited by 65
Autoimmune responses and inflammation in type 2 diabetes
Prasad, M., Chen, E. W., Toh, S.-A. E. S., & Gascoigne, N. R. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0220-243r · Cited by 78
Li, Q., Hu, J., Nie, Q., Chang, X., Fang, Q., Xie, J., Li, H., & Nie, S. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1647-6 · Cited by 69
Gut Microbiota: A Key Factor in the Host Health Effects Induced by Pesticide Exposure?
Meng, Z., Liu, L., Yan, S., Sun, W., Jia, M., Tian, S., Huang, S., Zhou, Z., & Zhu, W. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c04678 · Cited by 67
Gut microbiota and its metabolites: Bridge of dietary nutrients and obesity-related diseases
Zhou, M., Johnston, L. J., Wu, C., & Ma, X. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1986466 · Cited by 70
Flavonoids, gut microbiota, and host lipid metabolism
Zhou, M., Ma, J., Kang, M., Tang, W., Xia, S., Yin, J., & Yin, Y. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202300065 · Cited by 73
Vliex, L. M. M., Penders, J., Nauta, A., Zoetendal, E. G., & Blaak, E. E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00966-0 · Cited by 75
Potential role of bioactive compounds of Phaseolus vulgaris L. on lipid-lowering mechanisms
Ramírez‐Jiménez, A. K., Reynoso‐Camacho, R., Tejero, M. E., León‐Galván, M. F., & Loarca-Piña, G. F. (2015) · Food Research International · doi:10.1016/j.foodres.2015.01.002 · Cited by 75
Glenny, E. M., Bulik-Sullivan, E. C., Tang, Q., Bulik, C. M., & Carroll, I. M. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0797-3 · Cited by 65
Shen, H., Lu, Z., Xu, Z., Chen, Z., & Shen, Z. (2017) · Microbiome · doi:10.1186/s40168-017-0341-z · Cited by 69
Estrada, J. A., & Contreras, I. (2019) · Nutrients · doi:10.3390/nu11051076 · Cited by 66
Ligezka, A. N., Sonmez, A. I., Corral-Frias, M. P., Golebiowski, R., Lynch, B., Croarkin, P. E., & Romanowicz, M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110187 · Cited by 56
The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment
Liu, J. C. W., Gorbovskaya, I., Hahn, M., & Müller, D. J. (2021) · Nutrients · doi:10.3390/nu13041152 · Cited by 74
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 77
Zhou, W., Chen, G., Chen, D., Ye, H., & Zeng, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104222 · Cited by 66
He, X.-Q., Li, W., Chen, Y., Lin, L., Li, F., Zhao, J., Zeng, K., & Ming, J. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111386 · Cited by 64
The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis
Wang, H., Zhao, T., Liu, Z., Danzengquzhen, Cisangzhuoma, Ma, J., Li, X., Huang, X., & Li, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1197646 · Cited by 78
Bourgot, C. L., Apper, E., Blat, S., & Respondek, F. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0245-3 · Cited by 69
Altered Gut Microbiota: A Link Between Diet and the Metabolic Syndrome
Velasquez, M. T. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0163 · Cited by 72
Yuan, T., Chu, C., Shi, R., Cui, T., Zhang, X., Zhao, Y., Shi, X., Yan, H., Pan, J., Qian, R., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01436 · Cited by 68
Effects of infant formula composition on long-term metabolic health
Lemaire, M., Huërou‐Luron, I. L., & Blat, S. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417000964 · Cited by 71
Gut microbial metabolites and its impact on human health
Rahman, S., O'Connor, A. L., Becker, S. L., Patel, R. K., Martindale, R. G., & Tsikitis, V. L. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0809 · Cited by 105
The role of gastrointestinal vagal afferent fibres in obesity
Kentish, S. J., & Page, A. J. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.278226 · Cited by 62
Stimulation of GLP-1 Secretion Downstream of the Ligand-Gated Ion Channel TRPA1
Emery, E. C., Diakogiannaki, E., Gentry, C., Psichas, A., Habib, A. M., Bevan, S., Fischer, M. J. M., Reimann, F., & Gribble, F. M. (2015) · Diabetes · doi:10.2337/db14-0737 · Cited by 67
Self-citationNutrients related to GLP1 secretory responses
Mansour, A., Hosseini, S., Larijani, B. A., Pajouhi, M., & Mohajeri‐Tehrani, M. R. (2013) · Nutrition · doi:10.1016/j.nut.2012.11.015 · Cited by 74
Oleskin, A. V., Ba, S., & Rogovskii, V. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9262-1 · Cited by 68
Huber, H., Schieren, A., Holst, J. J., & Simon, M.-C. (2024) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.01.007 · Cited by 62
He, B., & Moreau, R. F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.002 · Cited by 66
Xie, C., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090790 · Cited by 67
de Souza, C. O., Sun, X., & Oh, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.715877 · Cited by 72
Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis
Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 65
Cooperative action of gut-microbiota-accessible carbohydrates improves host metabolic function
Tomioka, S., Seki, N., Sugiura, Y., Akiyama, M., Uchiyama, J., Yamaguchi, G., Yakabe, K., Ejima, R., Hattori, K., Kimizuka, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111087 · Cited by 64
Zhu, Y.-Y., Cong, W., Shen, L., Wei, H., Wang, Y., Wang, L., Ruan, K., Wu, F. L., & Feng, Y. (2013) · Molecular BioSystems · doi:10.1039/c3mb70392d · Cited by 65
Olli, K., Salli, K., Alhoniemi, E., Saarinen, M., Ibarra, A., Vasankari, T., Rautonen, N., & Tiihonen, K. (2015) · Nutrition Journal · doi:10.1186/1475-2891-14-2 · Cited by 59
Reimann, F., & Gribble, F. M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12478 · Cited by 64
Self-citationMartín‐Núñez, G. M., Cornejo-Pareja, I. M., Coín‐Aragüez, L., Roca-Rodríguez, M. D. M., Muñoz‐Garach, A., Clemente‐Postigo, M., Cardona, F., Moreno‐Indias, I., & Tinahones, F. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213548 · Cited by 67
Yu, D., Zhu, W., & Hang, S. (2019) · Archives of Animal Nutrition · doi:10.1080/1745039x.2019.1614849 · Cited by 69
Martchenko, S. E., Martchenko, A., Cox, B. J., Naismith, K., Waller, A., Gurges, P., Sweeney, M. E., Philpott, D. J., & Brubaker, P. L. (2020) · Diabetes · doi:10.2337/db20-0262 · Cited by 58
Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
Frausto, D. M., Forsyth, C. B., Keshavarzian, A., & Voigt, R. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736814 · Cited by 61
The Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 66
Hamamah, S., Hajnal, A. S., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu16071071 · Cited by 72
Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axis
Li, C., Yao, J., Yang, C., Yu, S., Yang, Z., Wang, L., Li, S., & He, N. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01554-5 · Cited by 69
Kezer, G., Paramithiotis, S., Khwaldia, K., Harahap, I. A., Čagalj, M., Šimat, V., Smaoui, S., Elfalleh, W., Özoğul, F., & Esatbeyoglu, T. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1651965 · Cited by 67
Zhang, L., Li, H. T., Shen, L., Fang, Q. C., Qian, L. L., & Jia, W. (2015) · PubMed · doi:10.3967/bes2015.040 · Cited by 57
Shirouchi, B., Nagao, K., Umegatani, M., Shiraishi, A., Morita, Y., Kai, S., Yanagita, T., Ogawa, A., Kadooka, Y., & Sato, M. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516002245 · Cited by 60
Zhan, J., Liang, Y., Liu, D., Ma, X., Li, P., Zhai, W., Zhou, Z., & Wang, P. (2019) · Environment International · doi:10.1016/j.envint.2019.05.055 · Cited by 62
Personalized dietary management of overweight and obesity based on measures of insulin and glucose
Hjorth, M. F., Zohar, Y., Hill, J. O., & Astrup, A. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051606 · Cited by 60
Montgomery, M. K., Osborne, B., Brandon, A. E., O’Reilly, L., Fiveash, C. E., Brown, S. H. J., Wilkins, B. P., Samsudeen, A., Yu, J., Devanapalli, B., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900234r · Cited by 67
Diet‐derived microbial metabolites in health and disease
Roager, H. M., & Dragsted, L. O. (2019) · Nutrition Bulletin · doi:10.1111/nbu.12396 · Cited by 61
Kumar, K. U., Anbazhagan, A. N., Priyamvada, S., Jayawardena, D., Kumar, A., Yang, C., Xia, Y., Finn, P. W., Perkins, D. L., Dudeja, P. K., et al. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00454.2019 · Cited by 65
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 72
Mechanistic Understanding of the Effects of Pectin on In Vivo Starch Digestion: A Review
Bai, Y., & Gilbert, R. G. (2022) · Nutrients · doi:10.3390/nu14235107 · Cited by 67
Short-chain fatty acids are potential goalkeepers of atherosclerosis
Feng, Y., & Xu, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271001 · Cited by 70
Sandberg, J. C., Björck, I., & Nilsson, A. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151985 · Cited by 73
Gong, J., Qiu, W., Zeng, Q., Liu, X., Sun, X., Li, H., Yang, Y., Wu, A., Bao, J., Wang, Y., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518790396 · Cited by 64
Metadata
- Authors
- Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M.
- Affiliations
- Addenbrooke's Hospital (GB)
- Takeda (United Kingdom) (GB)
- Corresponding author
- Reimann, Frank
- Gribble, Fiona M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-01-17
- Volume
- 61
- Issue
- 2
- Pages
- 364-371
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3266401
- OpenAlex
- W2168842536
- Cited by
- 2,404
- References
- 32
- Citations by year
- 2026: 266 · 2025: 233 · 2024: 203 · 2023: 183 · 2022: 245 · 2021: 205 · 2020: 215 · 2019: 151 · 2018: 158 · 2017: 120 · 2016: 132 · 2015: 103 · 2014: 92 · 2013: 65 · 2012: 27
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo
- Funders
- Wellcome Trust (084210/Z/07/Z, 088357/Z/09/Z, #WT084210, 088357, 088357/Z/09/A)
- European Commission (2007–2013, 266408)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, glucagon-like peptide-1, FFAR2, GPR43, GPR41, incretin secretion, gut microbiota, prebiotic fermentation, colonic epithelial cells, calcium signaling, glucose tolerance, diabetes treatment, Gq signaling
- MeSH terms
- Animals, Calcium, Colon, Fatty Acids, Volatile, Mice, Inbred C57BL, Signal Transduction, GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.